objective To determine the prevalence of diabetes mellitus (DM), assess its influence on healthrelated quality of life (HRQoL) among patients with TB.
Introduction
The association between diabetes mellitus (DM) and tuberculosis (TB) was of great concern at the beginning of the 20 th century, but disregarded later because treatments for both sicknesses were developed [1] . In recent decades, the considerable increase in people with diabetes is recognised to hamper effective TB control and causes re-emergence of this public health problem in India [2] . With approximately 23.0% TB incident cases and a 69.0 million DM cases, India's health system is under threat [3, 4] . DM triples the risk of TB and causes poor outcomes including treatment failure and death; therefore, it undermines TB control [5] .
Multiple studies from different setting have reported a wide range of DM prevalence, from 1.9% to 44%, among patients with TB [6] [7] [8] [9] [10] . Studies focusing on the impact of this comorbidity on health-related quality of life (HRQoL) of patients are lacking. Given the high DM burden in India, it becomes imperative to assess its influence on the social, physical and psychological wellbeing of patients with TB. Measuring HRQoL in TB with DM patients can play an important role in the evaluation of a wide range of factors which can explain many non-identified aspects of this comorbidity. It is also evident from previous studies that both TB and DM have a profound, multidimensional impact on patients' quality of life (QoL), including psychological and physical wellbeing [11] [12] [13] .
The DR-12 scale, developed in India by Dhingra and Rajpal in 2003 , is a multidimensional, disease-specific HRQoL instrument that has shown strong construct validity in the Indian population [14] . It consists of 12 questions pertaining to symptoms, physiological, psychological and social wellbeing of patients with TB [14] .
An integrated approach with regards to HRQoL is needed for successful management of patients with TB and DM. Quite a few studies have investigated the DM prevalence in north India, highlighting the need for more research describing the prevalence of this comorbidity in the country. Further, there is an urgent need to expand control efforts and identify the individual and social determinants to reduce the impact and prevent the colliding epidemics. Thus, our aim was to identify the risk factors associated with DM prevalence; to assess the influence of DM on the HRQoL of patients with TB; and to identify predictors of poor HRQoL scores.
Methods

Study design and setting
This was a prospective, multicentre, non-randomised, non-interventional study conducted at three randomly selected directly observed treatment (DOT) cum microscopy centres, viz. Mehrauli, Khanpur and Tigri in the urban slum area of south Delhi, India (Appendix S1). At present, 11 microscopy centres are in operation with the help of dedicated paramedic staff and trained laboratory technician in 1 million population of south zone of Delhi. All three DOT centres are affiliated with the tertiary care hospital, that is, National Institute of TB and Respiratory Diseases (NITRD), New Delhi. The institutional ethics committee (IEC) at Hamdard University and NITRD (NITRD/EC/2014/10293 & JHIEC-2014) approved the study. Patients were recruited from January 2014 to September 2014 and were followed-up till the end of treatment. Each subject or legal guardians/parents provided written informed consent for study participation. Details on the sample size and inclusion/exclusion criteria are published elsewhere [15] .
Eligible TB cases were examined for blood glucose estimation at the treatment initiation. Patients were divided into DM and non-DM category, based on their fasting/2-h plasma glucose status. The HRQoL evaluation was performed at three visits: visit 1 before treatment initiation; visit 2 at the end of the intensive phase of treatment (I.P); and visit 3 at the end of treatment.
TB diagnosis and estimation of blood glucose and HbA1c
Sputum smear examination for acid fast bacilli (AFB) was done by Ziehl-Neelsen staining technique in the laboratory of DOT cum microscopy for PTB patients. Diagnosis of EPTB was made on clinical presentation by the physician. All enrolled patients were screened for fasting blood glucose (FBG) at TB treatment initiation. Patients with FBG ≥110 mg/dl were repeated for 2-h PG after 75-g oral glucose tolerance test (OGTT) on the next day. DM was diagnosed if the 2-h PG was ≥200 mg/dl in accordance with international criteria [16] . In case of discordant results, the test with the result above the diagnostic cut-off point was repeated. Patients were considered as diabetic if both tests were above the diagnostic cut-off. The glycosylated haemoglobin (HbA1c) test was performed in people with diabetes at the end of I.P and of treatment to assess diabetes control. Patients with an average HbA1c <7% were considered as controlled diabetes, while patients with an HbA1c ≥7% were considered as uncontrolled diabetes.
Health-related quality of life assessment (DR-12 scale)
Despite the abundance of tools for measuring the HRQoL in patients with TB, the DR-12 scale was chosen as it has valid disease-specific measures and a minimal risk of reaching a misleading conclusion about the impact of treatment on the status of patient wellbeing. The questionnaire included the assessment of symptom score and socio-psychological & exercise adaptation score to assess the broad picture of the health. Evaluation of the DR-12 questionnaire provided evidence that it has a strong construct validity and is sensitive for detecting differences among groups [14] .
The DR-12 instrument has 12 components broadly divided into two domains of HRQoL. The first domain (score I) contains seven TB-specific symptoms (i.e. cough and sputum, hemoptysis, fever, breathlessness, chest pain, anorexia and weight loss). The second domain (score II) contains five questions related to interest in work, household activities, mental status, exercise and social adaptability (i.e. emotional symptoms/depression, interest in work, household, exercise and social activities). The first domain strongly correlates with symptom score and the second domain with socio-psychological & exercise adaptation score. The patients were asked to respond their perception on a scale of 1-3. All responses were presented on 3-point scales and equal weight was given to each item when calculating the two domain scores. The lower score was depicting the poor health status while higher depicting the relatively better perception. Estimation of these scores (scores I and II) were made at treatment initiation, end of IP and end of treatment. Composite scores were expressed, as total HRQoL score, by combining the scores of the individual domain [14] . The reliability of the questionnaire was tested by calculating internal consistency, and Cronbach's alpha reliability analysis was conducted for the overall HRQoL survey for both domains. The construct validity of DR-12 was examined by computing factor analysis.
Collection of covariates
A semi-structured pre-tested questionnaire was used to collect information regarding demography, habitual risk factors, psychological state and previous history of TB. The psychological state included emotional distress and social inactivity since 4 weeks before treatment initiation. Socio-economic status was determined by modified Kuppuswamy's status scale [17] . Data were also collected regarding the cost incurred (in INR) due to illness (medication, diagnosis, transportation and others), effect of illness on employment in terms of loss of workdays due to absenteeism (calculated only for employed patients) and debt incurred due to treatment at the initiation of therapy, at the end I.P and end of treatment. The help of the family head was also taken, whenever required, in estimating cost incurred in treatment.
Statistical analysis
Statistical analysis was performed using Statistical Package for the Social Sciences version 21.0 (SPSS, Inc., Chicago, IL, USA). Categorical variables were summarised as frequencies and percentages and analysed using chisquare test. Continuous variables were described using means, standard deviations and medians. Unpaired t-test and Wilcoxon's non-parametric rank sum test were used appropriately according to data distribution pattern. To determine the factors associated with diabetes prevalence, odds ratios (OR) and their 95% confidence intervals (CI) were calculated by multiple logistic regression analysis. The presence of diabetes was the dependent variable while others were the independent variables. Reliability was calculated by determining Cronbach's a, and factor analysis was used to compute validity of DR-12 items. A stepwise regression procedure was conducted to determine the predictors of HRQoL for both groups. A P value <0.05 was considered as statistically significant.
Results
Patient characteristics
A total of 546 patients with TB were diagnosed and subsequently treated at all three DOTS centres between the study duration. A total of 316 patients were enrolled in the study after excluding those who did not fulfil the inclusion criteria. Out of the total, 50 (15.8%) patients were diagnosed with DM and the remaining 266 (84.2%) had no DM. The DM prevalence in different types (PTB and EPTB) and categories of patients with TB (category I and category II) was reported elsewhere [15] . The DM was more prevalent in females (16.3%), compared to males (15.4%).
DM yield was more in patients with higher age group (36-45 and >45). A significantly greater proportion of patients with DM was married (P < 0.001), had higher BMI (body mass index; P < 0.001) and a history of tobacco and alcohol consumption (P < 0.001). More patients with DM were illiterate (34% vs. 12.4%), emotionally negative (P = 0.004) and socially inactive (P < 0.001). The baseline features of all enrolled patients are described in Table 1 .
Factors associated with TB with DM group
Multiple logistic regression revealed that advancing age, BMI, presence of PTB, literacy level and psychological status were significantly associated with DM. The odds of developing DM were greatest in patients >45 years of age (OR; 29.08, 95% CI; 8.03-105.33, P < 0.001) followed by those with higher (>23 kg/m 2 ) BMI (OR; 29.08, 95% CI; 8.03-105.33, P < 0.001). A greater probability of developing DM was observed in PTB patients (OR; 2.16, 95% CI; 1.10-4.26, P = 0.02). After adjusting for age, sex and BMI, older age (adj OR; 32.11, 95% CI; 6.22-124.21, P < 0.001) and higher BMI (adj OR; 19.18, 95% CI; 3.22-81.72) remained significant predictors for DM prevalence. Being married (P = 0.05), illiterate (P = 0.03) and emotionally negative (P = 0.04) were some other factors which was significantly associated with DM patients in adjusted model (Table 2) .
Patients with DM had spent a significantly larger amount of money, in terms of direct cost (investigation, medication, transportations and others) due to illness (P < 0.001). They further had incurred significantly more debt (P = 0.04) for their treatment. Other economic factors affected by the illness of patients were comparable between the two groups (Table 3 ).
HRQoL scores among TB patients with and without DM
Of 316 patients, 12 did not complete the study, 10 died and two defaulted during the study period. A total of 304 patients completed the study, of which 49 had DM and 255 had no DM. The results for HRQoL analysis were stratified into different age groups to control the effect of age. The scores of each domain of HRQoL at three different time points, that is at pre-treatment, end I.P and end of treatment, were presented in Figure 1a , 1b and 1c. A sign of improvement in HRQoL scores was observed at each subsequent visit in both groups at each domain (Appendix S1). Patients with DM >50 years of age presented with significantly poor HRQoL in symptom scores at treatment initiation (visit 1 st ), and sociopsychological & exercise adaptation scores at all visits. Moreover, in patients with 15-30 and 31-50-years of age groups, HRQoL scores were relatively poor in patients with TB and DM, compared to those of without DM, at both domains. However, this decline did not reach statistical significance, except for socio-psychological & exercise adaptation and total scores at pre-treatment visit in 15-30-years old patients.
In our study, 32 (66.0%) and 17 (34.0%) patients had controlled (average HbA1c <7%) and uncontrolled (average HbA1c ≥7%) DM, respectively. The HRQoL was poorer in uncontrolled DM patients than those of controlled DM patients; however, this decline in score did not reach at statistical significance for most of the visits. Uncontrolled DM patients had significantly poorer HRQoL scores at the 3 rd visit in both symptom score and total score than controlled DM patients (Table 4) . Data were analysed by chi-square test and *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 was considered as significant level. Above data were of 266 people with no diabetes and 50 people with diabetes taken before the treatment initiation. The reliability coefficients of both domains of the DR-12 tool, as assessed by Cronbach's a, at all three time points were between 0.71 and 0.87. The overall score for entire scale was 0.88, which is well above the standard cut-off of 0.7. The item consistency of all items in the DR-12 was ranging from 0.58 to 0.89 for both patients with and without DM. The correlations of items with their corresponding scales were significantly higher than other scales (P < 0.01).
Association of predictors and HRQoL scores
All independent variables were used in a stepwise multiple regression analysis to predict the HRQoL scores at visit 1 st and visit 3 rd (Tables 5 and 6 ). In TB patients with DM, literacy level and loss in workdays due to absenteeism predicted poor HRQoL scores in symptom and socio-psychological & exercise adaptation domains at the treatment initiation. Literacy level remained the most significant predictor (b = 0.43, P = 0.002) and received the strongest weight in the model. Additionally, age range (b = À0.42, P = 0.002), debt incurred (b = À0.30, P = 0.02) and socio-economic status (b = 0.28, P = 0.03) predicted the total HRQoL score at completion of treatment. In TB patients without DM, total HRQoL was predicted by type of TB (b = 0.43, P < 0.001), literacy level (b = 0.15, P = 0.007), debt Loss has been calculated only for employed patients. All these data were collected at the three visit, that is baseline, end I.P and end C.P. Data of only those patients who finished the study were included in the above table. All parameters were analysed by chi-square test to determine significance level. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 was considered significant; INR: Indian National Rupees. Mann-Whitney U test was used to compute the mean values of the two groups. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 was considered as significant. The range of scores in symptom score domain was 7 -21 (min. was 7 and max. was 21), socio-psychological & exercise adaptation domain were 5 -15 (min. was 5 and max. was 15) and total score was 12 -36 (min. was 12 and max. was 36). This data were on 49 people with diabetes (one patient was died during the treatment) and 255 (nine died and two defaulted during the treatment) people with no diabetes. In people with no diabetes, two patients had refused to answer at 2 nd visit while one at 3 rd visit. Patients who were not available for interview at visit 2 and visit 3 were excluded in HRQoL analysis. SS: symptom scores domain; ES: socio-psychological & exercise adaptation score domain; TS: total score; the numbers denotes the visits. All data were presented as mean AE SD and statistically analysed using Mann-Whitney U test and independent sample t-test, wherever required, and compared among controlled and uncontrolled DM patients at different visits. *P < 0.05 was considered as significant.
incurred (b = À0.15, P = 0.006) and marital status (b = 0.13, P = 0.01) at treatment initiation. Age (b = À0.17, P = 0.007) also predicted HRQoL scores at the completion of treatment.
Discussion
We found that the prevalence of DM (15.82%), among patients with TB, is higher than the national adult diabetes prevalence, estimated to be approximately 9% among adults [3] . Higher DM prevalence was observed in patients >35 years, illiterate patients, patients with higher BMI, poor psychological state and smear-positive TB. Furthermore, patients with DM >50 years showed significantly poorer HRQoL at each visit. HRQoL scores were significantly poorer in uncontrolled DM patients at the end of treatment in symptom scores and total scores. A growing body of evidence suggests that DM is highly prevalent among patients with TB, particularly in countries with the dual burden of both TB and DM [18] [19] [20] [21] . The DM prevalence in our study is comparable with the documented prevalence rate from other tropical countries [20, 21] . A case-control study from Indonesia reported 13.2% DM prevalence in patients with TB vs. 3.2% in matched control subjects [21] . Duangrithi et al.
[20] reported 16.3% DM prevalence in Thailand, of which 70.3% were diagnosed with DM prior to PTB diagnosis. An epidemiological model developed by Stevenson et al. [22] in India suggested 14.8% PTB and 20.2% smear-positive TB linked to DM. Studies from south India (25.0%, 29.0% and 44.0% in Tamilnadu, Pondicherry and Kerala, respectively), Pakistan (25.9%), South Korea (23.8%) and Mexico (29.6%) have reported substantially higher DM prevalence than our report [6, 7, 10, [23] [24] [25] . The diverse DM prevalence in different settings may also attributed to the methods of DM diagnosis, outcome definitions and failure to control for important confounders.
The significantly poorer HRQoL in advancing age, as observed in our study, is most often associated with degenerative changes, poor compliance with treatment modalities, incapability of lifestyle management, impairment of activities of daily living, declining work capacity and fatigue. Ageing further leads to decline in the immunity and T cell functioning which may worsen overall immunity and result in poor symptom scores at pre-treatment visit [26] . In agreement with our study, worse social and family life among people with diabetes, aged 41-60 years, were reported by Dudzinska et al. [27] . An inverse relationship between the HbA1c and overall improvement in HRQoL was documented in multiple studies [28, 29] . Impaired cell-mediated immunity in poorly controlled vs. controlled DM patients might have caused significantly poor HRQoL at the end of the 3 rd visit in symptom scores and total scores in our study. These findings clearly suggest that maintaining HbA1c within a desirable range could be a contributing factor for HRQoL improvement in TB with DM patients.
This study has some important implications for policymakers. Effective and efficient routine screening of DM should be implemented in all TB clinics and primary health centers (PHC) and people found with diabetes must be referred to a DM care unit. Early screening for DM is of more importance in patients at high risk. The population should be sensitised to avoid unnecessary delay in screening and then treatment initiation. We demonstrated that good glycemic control within a desirable range could be a contributing factor for HRQoL improvement. The patients should be educated on the importance of better DM management strategies on the TB treatment outcome. Poor HRQoL among TB with DM patients, even after the completion of treatment, calls for urgent attention of healthcare practitioners to assess the patient-reported outcomes at different stages of the treatment. This strategy will help clinicians to take appropriate measures for addressing the physical, sociopsychological and mental wellbeing of the patients. To get a good measure of patients with DM linked to TB, more epidemiological studies using the same methodology should be replicated in different settings in India and other high DM burden countries.
The limitations of our study include those that are inherent to open-label observational studies. The impact of selection bias on the results of this study must be considered. Given the substantially higher proportion of newly diagnosed patients with DM, one cannot rule out the possibility of selection bias as transient hyperglycaemia is frequent during TB. Moreover, the geographic distribution of the study population was not representative of the general population and may raise questions regarding generalisability of the results. However, selection bias was minimised by relying on laboratory tests rather than medical records to determine DM status. Considering biological variation in blood glucose levels and measurement error, DM was diagnosed on the basis of repeat glucose measurements instead of one-point estimation [30] . Further, we restricted our study to new and retreatment TB cases (category I and category II) confined to an urban slum area of south Delhi.
Currently, we lack an integrated multidisciplinary approach on good DM management that is helpful in decreasing the risk of TB and improving TB treatment outcomes [31] . The collaborative framework, established by the World Diabetes Foundation and IUATLD in 2011, underlines the need for the joint program to control DM and TB and guide policy makers in combatting the TB-DM epidemic [32] . The convergence of two epidemics essentially requires further research in high DM prevalence settings to meet the challenges which can overcome complications in TB treatment outcome. Conducting operational, clinical and patient-reported outcome research along with exploring underlying molecular mechanisms might identify new markers which can help in optimising the intervention strategies [33] . Routinely and actively screening all patients with TB reduces the risk of poor TB treatment outcome [6] . Better glycemic control, increasing awareness of patients and healthcare providers, operational research in countries with the dual burden of TB and DM, and characterising the risk and predictors for poor HRQoL, are needed for better results. Further prospective longitudinal interventional randomised studies covering larger samples of urban and rural populations are necessary.
Conclusion
The high DM prevalence in patients with TB calls for routine DM screening in all TB clinics and DOT cum microscopy centres. People found with diabetes must be referred to DM care units for better DM control, which can also improve the patients' wellbeing. Better education can be associated with more self-confidence, a positive attitude towards illness and social status; hence it could be an important means of improving the HRQoL. We emphasise the importance of good glycemic control to lift the HRQoL in TB patients with DM.
